Among 335 cases and 5,548 controls, PGSPSA was not associated with prostate cancer incidence (pooled: OR per s.d. = 1.01, P = 0.83), confirming that it captures genetic determinants of non-cancer PSA variation. This evidence concerns the gene KLK3 and prostate cancer.